Immunology Drugs Market Poised for Breakthrough Growth Amid Rising Autoimmune and Inflammatory Disorder Cases 2025 | Top key players - Eli-Lilly, Novartis, AbbVie.

Market Size and Growth:

The Global Immunology Drugs Market Size reached US$ 91.97 billion in 2023 and is expected to reach US$ 148.62 billion by 2031, growing at a CAGR of 6.35% during the forecast period 2024-2031.

The Immunology Drugs Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants to capitalize on these opportunities. Overall, the Immunology Drugs market report is an essential resource for market participants who are looking to gain a comprehensive understanding of the market and identify opportunities for growth.

Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: https://datamintelligence.com/download-sample/immunology-drugs-market?sz

The Immunology Drugs Market refers to the global industry focused on developing, manufacturing, and commercializing drugs that modulate or suppress immune system responses. These drugs are used to treat autoimmune diseases, inflammatory conditions, allergies, and immunodeficiency disorders. The market includes biologics, monoclonal antibodies, and small-molecule therapies, driven by rising disease prevalence, technological advances, and growing demand for targeted treatments.

Key Developments of USA and Japan:

USA:

Sanofi's Wayrilz (rilzabrutinib) approved for immune thrombocytopenia: On August 29, 2025, the FDA approved Wayrilz as the first BTK inhibitor for persistent or chronic immune thrombocytopenia in adults. It works by a multi-immune modulation approach.

Approval of drugs for hereditary angioedema: In August and July 2025, the FDA approved several drugs for hereditary angioedema (HAE), including Dawnzera (donidalorsen) and Ekterly (sebetralstat) for on-demand treatment of HAE attacks, and Andembry (garadacimab-gxii) for prophylaxis.

Japan:

Changes to drug pricing and regulatory processes: The Ministry of Health, Labour and Welfare (MHLW) and the Pharmaceuticals and Medical Devices Agency (PMDA) have implemented changes in 2025 to streamline drug development and reduce the "drug lag" compared to Western countries. This includes increasing the number of annual opportunities to assign drug pricing to seven.

Regulatory focus on innovative therapies: Japan has been focusing on accelerating the approval of innovative therapies like gene therapies and antibody-drug conjugates. The country is also encouraging the development of pediatric drugs and decentralized clinical trials.

Key Players:

Eli Lilly
Novartis
AbbVie
Sun Pharmaceuticals
Johnson &Johnson
ViiV Healthcare
Bristol-Myers Squibb
Gilead
Pfizer Inc
GlaxoSmithKline plc.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=immunology-drugs-market

Market Segmentation:

By Drug Type: Monoclonal Antibodies, Antibody Drug Conjugates, Immunosuppressive medication, Interferon and Cytokine Therapies.

By Therapy Type: Rheumatoid Arthritis, Psoriasis, Inflammatory Bowel Disease, Graft Versus Host Disease, Others.

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/immunology-drugs-market?sz

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Immunology Drugs market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Immunology Drugs Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Immunology Drugs market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Immunology Drugs Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Immunology Drugs Market in 2025?
◆ What is the projected growth rate of the Immunology Drugs Market through 2033?
◆ Who are the key players in the Immunology Drugs Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.